These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15919903)

  • 21. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
    Nakamura T; Sato K; Hamada H
    J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.
    Korokhov N; Mikheeva G; Krendelshchikov A; Belousova N; Simonenko V; Krendelshchikova V; Pereboev A; Kotov A; Kotova O; Triozzi PL; Aldrich WA; Douglas JT; Lo KM; Banerjee PT; Gillies SD; Curiel DT; Krasnykh V
    J Virol; 2003 Dec; 77(24):12931-40. PubMed ID: 14645549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
    Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR
    J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
    Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
    J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response.
    Rogée S; Grellier E; Bernard C; Jouy N; Loyens A; Beauvillain JC; Fender P; Corjon S; Hong SS; Boulanger P; Quesnel B; D'Halluin JC; Colin M
    Gene Ther; 2010 Jul; 17(7):880-91. PubMed ID: 20393506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.
    Khare R; May SM; Vetrini F; Weaver EA; Palmer D; Rosewell A; Grove N; Ng P; Barry MA
    Mol Ther; 2011 Jul; 19(7):1254-62. PubMed ID: 21505422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
    Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC
    Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
    Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus de-targeting from the liver.
    Di Paolo NC; Shayakhmetov DM
    Curr Opin Mol Ther; 2009 Oct; 11(5):523-31. PubMed ID: 19806500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
    Liu Q; Zaiss AK; Colarusso P; Patel K; Haljan G; Wickham TJ; Muruve DA
    Hum Gene Ther; 2003 May; 14(7):627-43. PubMed ID: 12804145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo.
    Tian J; Xu Z; Moitra R; Palmer DJ; Ng P; Byrnes AP
    PLoS Pathog; 2022 Sep; 18(9):e1010859. PubMed ID: 36156097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions.
    Wang H; Li Z; Yumul R; Lara S; Hemminki A; Fender P; Lieber A
    J Virol; 2011 Jul; 85(13):6390-402. PubMed ID: 21525338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver.
    Smith JS; Xu Z; Tian J; Stevenson SC; Byrnes AP
    Hum Gene Ther; 2008 May; 19(5):547-54. PubMed ID: 18447633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.
    Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH
    J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.
    Corjon S; Gonzalez G; Henning P; Grichine A; Lindholm L; Boulanger P; Fender P; Hong SS
    PLoS One; 2011; 6(5):e18205. PubMed ID: 21637339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
    Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
    Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.
    Wang H; Liu Y; Li Z; Tuve S; Stone D; Kalyushniy O; Shayakhmetov D; Verlinde CL; Stehle T; McVey J; Baker A; Peng KW; Roffler S; Lieber A
    J Virol; 2008 Nov; 82(21):10567-79. PubMed ID: 18753195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.